Literature DB >> 24429316

Chest X-ray vs. Xpert® MTB/RIF assay for the diagnosis of sputum smear-negative tuberculosis in Uganda.

C Wekesa1, B J Kirenga2, M L Joloba3, F Bwanga3, A Katamba2, M R Kamya2.   

Abstract

SETTING: An out-patient clinic in a country with high rates of tuberculosis-human immunodeficiency virus (TB-HIV) co-infection.
DESIGN: Cross-sectional analytical study of 123 adults with chronic cough and no previous anti-tuberculosis treatment. Demographic, clinical, chest X-ray (CXR) and GeneXpert® MTB/RIF data were collected. Proportions of TB diagnoses using both tests were calculated and compared using an unpaired t-test.
RESULTS: Sixty-six patients (53.7%) were female and 35 (28.5%) tested positive for HIV; 21 (17.1%) were Xpert-positive, while 51 (42.5%) had CXR suggestive of TB (P = 0.0018), of whom only 15 (29.4%) were Xpert-positive. CXR was suggestive of pulmonary TB in 15 (71.4%) of the 21 patients with a positive Xpert test.
CONCLUSIONS: The majority of the sputum smear-negative patients did not have TB on single Xpert testing. CXR gave an overestimate of sputum smear-negative TB cases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24429316     DOI: 10.5588/ijtld.13.0464

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  7 in total

1.  Association of Radiological Findings with the Xpert MTB/RIF Test in Patients with Suspected Pulmonary Tuberculosis.

Authors:  Wilson Oliveira Ezequiel Neto; Giovana Rodrigues Pereira; Márcia Silva Barbosa; Natan José Dutra Dias; Denise Rossato Silva
Journal:  Lung       Date:  2018-09-03       Impact factor: 2.584

2.  Utilization and Clinical Value of Diagnostic Modalities for Tuberculosis in a High HIV Prevalence Setting.

Authors:  Stephanie Gati; Rhoda Chetty; Douglas Wilson; Jacqueline M Achkar
Journal:  Am J Trop Med Hyg       Date:  2018-06-07       Impact factor: 2.345

3.  Quality of care for tuberculosis and HIV in the private health sector: a cross-sectional, standardised patient study in South Africa.

Authors:  Jody Boffa; Sizulu Moyo; Jeremiah Chikovore; Angela Salomon; Benjamin Daniels; Ada T Kwan; Madhukar Pai; Amrita Daftary
Journal:  BMJ Glob Health       Date:  2021-05

4.  Outcomes of a clinical diagnostic algorithm for management of ambulatory smear and Xpert MTB/Rif negative HIV infected patients with presumptive pulmonary TB in Uganda: a prospective study.

Authors:  Simon Walusimbi; Fred Semitala; Freddie Bwanga; Melles Haile; Ayesha De Costa; Lucian Davis; Moses Joloba; Sven Hoffner; Moses Kamya
Journal:  Pan Afr Med J       Date:  2016-03-31

5.  Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda.

Authors:  Simon Walusimbi; Brendan Kwesiga; Rashmi Rodrigues; Melles Haile; Ayesha de Costa; Lennart Bogg; Achilles Katamba
Journal:  BMC Health Serv Res       Date:  2016-10-10       Impact factor: 2.655

6.  Role of GeneXpert MTB/Rif Assay in Diagnosing Tuberculosis in Pregnancy and Puerperium.

Authors:  Zaiyad G Habib; Farouq M Dayyab; Abdallah Sanda; Sirajo H Tambuwal; Mahmood M Dalhat; Hamza Muhammad; Garba Iliyasu; Ibrahim Nashabaru; Abdulrazaq G Habib
Journal:  Case Rep Infect Dis       Date:  2015-08-03

7.  Diagnostic Accuracy of Xpert MTB/RIF in Sputum Smear-Negative Pulmonary Tuberculosis.

Authors:  Waqas Rasheed; Nisar Ahmed Rao; Hatem Adel; Mirza Saifullah Baig; Syed Omair Adil
Journal:  Cureus       Date:  2019-08-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.